Pacific Health Laboratories Endurox® R4®
Item # 049509
Size: 14 Servings
The product quantity for an item in your shopping cart has exceeded our Maximum Purchasing Policy. Please adjust your quantity to (12) and try again.
Your product couldn't be added to the basket because it is out of stock.
DescriptionThe Proven Science.
Endurox® R4®with it's patented ratio of carbohydrate to protein (4:1) plus antioxidants, electrolytes and glutamine, is proven to help muscles:
Replenishes muscle glycogen levels 128% more than a carbohydrate drink*
Carb/Protein formula rebuilds muscle protein 38% more than a protein drink.
Reduces post-exercise muscle damage up to 36%.
Come Back Stronger
Extends endurance up to 55% in a subsequent workout.
Endurox® R4® Recovery Drink
The drink that advanced the science of muscle recovery.
Developed by leading exercise physiologists Endurox® R4®, with its patented ratio of carbohydrates to protein, is proven to speed muscle recovery and reduce muscle damage following exercise. No product can help your muscles rebuild and recover faster.
And, because different athletes have different recover needs, we’ve also created Endurox® Restore, for exercise bouts lasting less than one hour. Both improved Endurox® R4 and Endurox® Restore contain the proven and patented science of the 4-1 carbohydrate to protein ratio.
PRODUCT DIRECTIONS / ADDITIONAl INFOMix 2 scoops with 12 ounces of cold water. Take immediately after exercise.
Other IngredientsDextrose, Whey Protein Concentrate, Complex Carbohydrates, Fructose, Sucrose, Citric Acid, Magnesium Carbonate, Natural Flavors, Ascorbic Acid, Sodium Chloride, L-Glutamine, Vitamin E Acetate, Lecithin, Monopotassium Phosphate, Yellow 5, Blue 1
StorageStore at room temperature(55-85 degrees F., Avoid excess heat above 104oF (40oC).
©2008 PacificHealth Laboratories, Inc. All rights reserved. Manufactured for PacificHealth Laboratories, Inc. Matawan, NJ 07747 Endurox® R4® is a registered trademark of PacificHealth Laboratories, Inc. U.S. patent #6,051,236. Additional patents pending.